CT Coronary Imaging: High-Precision Screening for Intermediate-Risk Men

Standard cardiovascular risk calculators (Framingham, ASCVD, SCORE2) use age, sex, blood pressure, cholesterol, smoking and diabetes to produce a probability of an event in the next ten years. They work reasonably well at the extremes - someone clearly low-risk usually is, someone clearly high-risk usually is - but the majority of middle-aged men land in an intermediate band where the calculator alone cannot tell you whether to start a statin, how tightly to drive LDL, or whether to consider aspirin.

CT coronary imaging cuts through this ambiguity by showing the disease itself, not a statistical estimate. Plaque is either present in your arteries or it is not. That binary, plus the quantitative score, reclassifies a large share of intermediate-risk men: roughly half are moved down (low burden, defer therapy, recheck in years) and a meaningful minority are moved up (significant burden, start treatment earlier and more aggressively than the calculator suggested).

This is the key shift in modern preventive cardiology: stop treating averages, start treating the individual artery.

The CAC scan is a non-contrast CT of the heart that takes a few minutes, requires no preparation, no needles and no medication, and delivers a radiation dose of roughly 1 mSv - similar to a few months of natural background radiation, and well below a standard chest CT.

The result is the Agatston score, a number reflecting the amount of calcified plaque in your coronary arteries:

• 0: no detectable calcified plaque. In a man over 45 this is genuinely reassuring and substantially lowers estimated 10-year event risk.
• 1 to 99: mild plaque. Suggests subclinical disease and usually shifts the plan toward earlier preventive therapy.
• 100 to 399: moderate plaque. Typically reclassifies the patient as high-risk and justifies statin therapy with a tighter LDL target.
• 400 or above: extensive plaque. Very high cardiovascular risk; intensive multi-factor prevention is warranted.

The score does not measure soft, non-calcified plaque and does not assess lumen narrowing - for that, CTCA is the right test.

CTCA is a contrast-enhanced CT that produces three-dimensional images of the coronary arteries themselves: the lumen, the vessel wall, calcified plaque and soft (non-calcified) plaque. It is typically performed with a heart-rate-lowering medication beforehand so the scanner can capture motion-free images, and it uses iodinated contrast.

CTCA is the right test, instead of (or in addition to) a CAC score, when:

• A younger man with a strong family history of premature coronary disease needs the most sensitive imaging - soft plaque can be present even when calcium is zero.
• The patient has atypical chest pain, breathlessness on exertion, or borderline stress test findings, and obstructive disease needs to be ruled out non-invasively.
• The CAC score is moderate and the question is whether there is significant lumen narrowing in any single vessel.
• An invasive coronary angiogram is being considered but a non-invasive alternative is preferable.

Large trials (SCOT-HEART, PROMISE) have shown that adding CTCA to standard care reduces non-fatal myocardial infarction over 5 years, principally by getting the right men onto preventive therapy earlier.

The point of the scan is not the number itself, it is what changes the next morning. Three concrete patterns:

• 50-year-old man, borderline LDL, no family history, CAC = 0. Statin can usually be deferred. Plan: lifestyle, blood-pressure target, recheck CAC in 5 years.
• Same man, CAC = 150. Reclassified to high risk. Start statin (often plus ezetimibe), tighten LDL target by one band, treat blood pressure to target, consider low-dose aspirin if bleeding risk allows. The scan is what triggers therapy that would otherwise have been delayed.
• 45-year-old man, strong family history, CAC = 0 but CTCA shows non-calcified plaque. Soft plaque without calcium is a meaningful finding; treat as high-risk despite the zero CAC. Aggressive LDL lowering and full risk-factor control.

This is what "high-precision, targeted prevention" means in practice: each man's treatment intensity is set by what is actually in his arteries, not by a population-average risk score.

Our MMC-registered medical team orders CAC scoring and CTCA directly at partner hospitals as part of your cardiovascular workup. You do not need a prior specialist consultation. This is faster and lower total cost than the conventional GP-to-cardiologist-to-scan pathway.

Your personal health concierge handles the entire process: booking the scan at a convenient partner hospital, receiving the images and the radiologist's report, and integrating the findings into your wider preventive plan. If the result warrants formal cardiology review (for example, significant lumen stenosis on CTCA), your concierge arranges that referral too.

A CAC scan uses roughly 1 mSv - similar to a few months of natural background radiation. A CTCA uses more (typically 3 to 5 mSv with modern protocols) because of the wider acquisition window and the need for higher temporal resolution. Both are well within the dose ranges considered acceptable for clinically indicated cardiac imaging.

CT coronary imaging is not for everyone. It is most valuable in men at intermediate calculated risk where the result will change management. It adds little for men who are clearly low-risk (where treatment is already not indicated) or for men with already-established cardiovascular disease (where treatment is already at maximal intensity). CTCA additionally requires iodine contrast, so it is avoided in significant contrast allergy or severely impaired kidney function.